To investigate the metastatic potential of HL tissues having an abundance of CD30+/FGF2+/SDC1+ cells and poor clinical outcome, tissue sections were immunostained for TGFβ1 and MMP9 expression (Figure 4A). This evidence concerns the gene SDC1 and Hodgkins lymphoma.